Clinical manifestations of diabetic cardiomyopathy
نویسنده
چکیده
Patients with diabetes have an increased incidence of heart failure, even after analyses have controlled for coronary artery disease and hypertension. Thus, as diabetic cardiomyopathy (DCM) has become a well recognized entity among clinicians, a better understanding of its development is necessary for the early diagnosis and the future treatment of diabetes-associated cardiovascular disease. In this article, the latest clinical research on the diagnosis and manifestations of DCM will be outlined. The discussion will be focused on the structural, functional, and metabolic changes that occur in the diabetic myocardium and how these changes contribute to the development of DCM in humans. Heart Metab. 2009;45:10–14.
منابع مشابه
A Review on 17-β estradiol a Potent Therapeutic Factor of Diabetic Cardiomyopathy
Type 2 diabetes causes structural and functional changes in the myocardium, which is called cardiomyopathy. Diabetic cardiomyopathy (DCM) is a distinct primary disorder process, independent of coronary artery disease, which leads to heart failure in diabetic patients. Also, DCM is a multifaceted disorder that is one of the leading causes of death in elderly and postmenopausal women. Menopause i...
متن کاملProxisome prolifrator-activated receptors alpha and delta in diabetic cardiomyopathy
Peraxisome prolifrator-activated receptors (PPARs) are a group of nuclear receptors comprising three isoforms termed alpha, beta/delta and gamma. PPARs can modulate metabolic processes especially fatty acid (FA) metabolisms via exerting transcriptional control on activating genes involved in fuel utilization. Thus, they can exert positive role in controlling chronic diseases such as diabetes. A...
متن کاملIs cardiac autonomic neuropathy the basis of nonischemic diabetic cardiomyopathy?
Autonomic diabetic neuropathy is a common and serious complication of diabetes mellitus with variable multiple organ involvement, principally of the cardiovascular system, but also of the gastrointestinal and urogenital tracts (1). Cardiac autonomic neuropathy (CAN) causes alterations in heart rate control and vascular dynamics, which may result in disabling clinical and functional manifestatio...
متن کامل11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity
11β-HSD1 has been recognized as a potential therapeutic target for type 2 diabetes. Recent studies have shown that hyperglycemia leads to activation of 11β-HSD1, increasing the intracellular glucocorticoid levels. Excess glucocorticoids may lead to the clinical manifestations of cardiac injury. Therefore, the aim of this study is to investigate whether 11β-HSD1 activation contributes to the dev...
متن کاملCell therapy in dilated cardiomyopathy: from animal models to clinical trials.
Dilated cardiomyopathy can be the end-stage form and common denominator of several cardiac disorders of known cause, such as hypertensive, ischemic, diabetic and Chagasic diseases. However, some individuals have clinical findings, such as an increase in ventricular chamber size and impaired contractility (classical manifestations of dilated cardiomyopathy) even in the absence of a diagnosed pri...
متن کامل